These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4120084)

  • 1. [Frequency of Mycobacterium tuberculosis L-form induction under the influence of cycloserine and its combinations with other drugs].
    Dorozhkova IR; Volk AV
    Antibiotiki; 1972 Sep; 17(9):838-44. PubMed ID: 4120084
    [No Abstract]   [Full Text] [Related]  

  • 2. [Induction of L-forms of Mycobacterium tuberculosis under the action of ethambutol, ethionamide and their combinations with some antibiotic and tuberculostatic drugs].
    Dorozhkova IR; Volk AV
    Antibiotiki; 1973 Feb; 18(2):144-8. PubMed ID: 4130173
    [No Abstract]   [Full Text] [Related]  

  • 3. [Dihydrostreptomycin as a factor inducing L-forms in Mycobacterium tuberculosis].
    Dorozhkova IR; Volk AV
    Antibiotiki; 1972 Oct; 17(10):915-22. PubMed ID: 4121154
    [No Abstract]   [Full Text] [Related]  

  • 4. [Phases of morphogenesis of L forms of Mycobacterium tuberculosis, developing on exposure to antibiotics and tuberculostatic agents].
    Dorozhkova IR; Volk AV
    Zh Mikrobiol Epidemiol Immunobiol; 1973 Nov; 50(11):12-8. PubMed ID: 4131407
    [No Abstract]   [Full Text] [Related]  

  • 5. [Ability of rifampicin and its combinations with other drugs to induce L-forms in Mycobacterium tuberculosis].
    Volk AV; Dorozhkova IR
    Antibiotiki; 1973 Aug; 18(8):706-10. PubMed ID: 4130174
    [No Abstract]   [Full Text] [Related]  

  • 6. [Criteria of resistance of some antibiotics and chemotherapeutics for strains of Mycobacterium tuberculosis isolated in Czechoslovakia. Cycloserin, ethionamide, pyrazinamide, rifampicin, and ethambutol (author's transl)].
    Víznerová A
    Cas Lek Cesk; 1979 Feb; 118(8):240-5. PubMed ID: 109213
    [No Abstract]   [Full Text] [Related]  

  • 7. [Interactions of antitubercular drugs. II. Combined effects of rifampin, ethambutol, capreomycin, viomycin, ethionamide and cycloserine on mycobacterial growth in vitro].
    Janowiec M; Zwolska-Kwiek Z
    Pneumonol Pol; 1983 Dec; 51(12):607-12. PubMed ID: 6199778
    [No Abstract]   [Full Text] [Related]  

  • 8. [Studies on the susceptibility of secondary anti-tuberculosis drugs (with special reference to the resistance-stabilities of cycloserine and ethionamide-resistant bacilli)].
    Hayashi S
    Kumamoto Igakkai Zasshi; 1970 Feb; 44(2):135-43. PubMed ID: 4986047
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of antitubercular agents of the 2d series: ethionamide, ethoxyd cycloserine and pyrazinamide on the development of drug resistance of Mycobacterium tuberculosis to tubazide and phthivazide].
    Makeeva OO
    Farmakol Toksikol; 1969; 32(2):202-5. PubMed ID: 4977183
    [No Abstract]   [Full Text] [Related]  

  • 10. [L-transformation of Mycobacterium tuberculosis strains isolated from patients treated with antibiotics].
    Kochemasova ZN; Dykhno MM; Prozorovskiĭ SV; Kassirskaia NG; Bakanova DIa
    Probl Tuberk; 1968; 46(8):64-7. PubMed ID: 4179328
    [No Abstract]   [Full Text] [Related]  

  • 11. [Development of resistance of Mycobacterium tuberculosis to cycloserine, ethionamide, kanamycin, florimycin in experiments in vitro].
    Mkrtchian SV
    Antibiotiki; 1968 Oct; 13(10):907-10. PubMed ID: 4303355
    [No Abstract]   [Full Text] [Related]  

  • 12. [The proportion method of determination of the resistance of tubercle bacilli to ethionamide, cycloserine and viomycin].
    Zduńczyk-Pawelek H
    Gruzlica; 1966 Mar; 34(3):255-63. PubMed ID: 4287801
    [No Abstract]   [Full Text] [Related]  

  • 13. [Resistance of the tuberculosis bacillus to ethionamide, cycloserine, and viomycin noting coexistant resistance to streptomycin, isonicotinic acid, and para-aminosalicylic acid].
    Rudnicka M; Suszko K
    Med Dosw; 1966; 33():291-302. PubMed ID: 4287506
    [No Abstract]   [Full Text] [Related]  

  • 14. [Criteria of clinical resistance of cycloserine, ethionamide and ethambutol].
    Okamoto K; Watanabe S; Terunuma K
    Kekkaku; 1970 Feb; 45(2):65-72. PubMed ID: 4985702
    [No Abstract]   [Full Text] [Related]  

  • 15. Experiences of the cycloserine sensitivity tests performed at the second chemotherapy trial of the IUAT.
    Lind A
    Scand J Respir Dis Suppl; 1970; 71():279-84. PubMed ID: 4989518
    [No Abstract]   [Full Text] [Related]  

  • 16. [The effect of antitubercular preparations on the sub-bacteriostatic action of cycloserine and ethionamide].
    Mkrtchian SV
    Probl Tuberk; 1968; 46(9):62-4. PubMed ID: 5718433
    [No Abstract]   [Full Text] [Related]  

  • 17. [Heterogeneity of drug-resistant strains of Mycobacterium tuberculosis].
    Belogurova VP
    Probl Tuberk; 1970; 48(9):76-9. PubMed ID: 4996497
    [No Abstract]   [Full Text] [Related]  

  • 18. [In-vitro potentiation of the anti-tuberculous effects of rifampicin and ethionamide by 4,4-diamino-diphenylsulphone (author's transl)].
    Havel A; Rosenfeld M
    Prax Pneumol; 1975 Aug; 29(8):453-8. PubMed ID: 810789
    [No Abstract]   [Full Text] [Related]  

  • 19. [Studies on the induction of the L-form in Mycobacteria].
    Zhuang YH
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1984 Aug; 7(4):210-2, 253. PubMed ID: 6443303
    [No Abstract]   [Full Text] [Related]  

  • 20. [Studies on tubercle bacilli resistant to secondary drugs in the resected specimens and sputum of pulmonary tuberculosis patients].
    Kameda K; Kudo S; Iwai K; Ushikubo K
    Kekkaku; 1970 Sep; 45(9):283-7. PubMed ID: 4989932
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.